The activation of the NAMPT/NAD + /SIRT1 signaling pathway has been shown to optimize bile acid composition and decrease the production of proinflammatory cytokines, thereby ameliorating metabolic disorders in MASH model animals [123,153]. This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatohepatitis.